Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 9Terminated 6Active not recruiting 5Completed 4Unknown 3Not yet recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1

Conditions

Urinary Bladder Neoplasms 2Sarcoma 1Pathologic Complete Response 1Neoplasms 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × Transurethral Resection of Bladder × Clear all
NCT06324058 2024-03-21

Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC

Huashan Hospital

Phase NA Unknown
190 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT05684874 2023-10-30

SarQuantIRM

Centre Leon Berard

Phase NA Unknown
25 enrolled
Sarcoma

Pathologic Complete Response, Neoplasms, Sarcoma

NCT05445648 2022-12-28

CBPTMI

First Affiliated Hospital Xi'an Jiaotong University

Phase 2 Unknown
65 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡